Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    My account
    Logout
AI 90-DAY FORECAST
NEUTRAL SIGNAL
██.█% Sign up free to reveal

Mirum Pharmaceuticals, Inc. (MIRM) AI Forecast

Our AI analyzed Mirum Pharmaceuticals, Inc.. Create a free account to see the 90-day price prediction.

✓ Free account • ✓ 30-day free trial

$MIRM Neutral Signal Full forecast available
Sign Up Free

Mirum Pharmaceuticals, Inc. (MIRM) Stock Forecast 2025

Mirum Pharmaceuticals, Inc. (MIRM) AI Stock Price Forecast & Investment Analysis

Mirum Pharmaceuticals, Inc. Stock Price Chart and Technical Analysis

Loading chart...

Mirum Pharmaceuticals, Inc. (MIRM) - Comprehensive Stock Analysis & Investment Research

Deep dive into Mirum Pharmaceuticals, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on June 12, 2026, 9:49 a.m. (UTC)

Mirum Pharmaceuticals, Inc. Investment Summary

When evaluating whether Mirum Pharmaceuticals, Inc. (MIRM) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Mirum Pharmaceuticals, Inc. (MIRM) operates within the Life Sciences sector, specifically in the Pharmaceutical Preparations industry. . With a market capitalization of $6 billion, the company is a mid-cap stock that typically offers a balance between growth potential and established business operations.

Financial Performance Analysis

Our comprehensive financial analysis covers Mirum Pharmaceuticals, Inc.'s revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Mirum Pharmaceuticals, Inc. along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Mirum Pharmaceuticals, Inc. is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Mirum Pharmaceuticals, Inc.

Sign Up Free
Corporate Identity

Mirum Pharmaceuticals, Inc. (Stock Symbol: MIRM) is a prominent company operating within the Life Sciences sector, with a specific focus on the Pharmaceutical Preparations industry. The company's shares are publicly traded on the Nasdaq exchange.

Leadership & Workforce

Detailed information about Mirum Pharmaceuticals, Inc.'s leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Mirum Pharmaceuticals, Inc....

Sector & Industry Analysis

In-depth sector dynamics and industry context for Mirum Pharmaceuticals, Inc....

Unlock Full Company Profile

Get complete details about Mirum Pharmaceuticals, Inc.

Sign Up Free
Revenue & Growth Analysis

Mirum Pharmaceuticals, Inc. generates annual revenues of $569 million , representing an emerging company in its growth phase.

Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Mirum Pharmaceuticals, Inc....

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Mirum Pharmaceuticals, Inc....

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Mirum Pharmaceuticals, Inc....

Unlock Financial Analysis

Get complete financial metrics for Mirum Pharmaceuticals, Inc.

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Mirum Pharmaceuticals, Inc.'s AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial →

✓ 30-day free trial • ✓ Cancel anytime

Strategic Market Position

Mirum Pharmaceuticals, Inc. strategically competes in the highly dynamic Pharmaceutical Preparations marketplace. As a mid-cap company, it occupies an attractive position balancing growth potential with established operations. Mid-caps often represent the 'sweet spot' for investors seeking companies that have proven their business models but still have meaningful runway for expansion. These companies are large enough to have competitive advantages but nimble enough to adapt quickly to market changes.

Industry Competitive Landscape

Mirum Pharmaceuticals, Inc. competes within the Life Sciences sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency

The company currently shows negative free cash flow of $-173 million . Negative free cash flow may reflect heavy investment in growth, working capital needs, or operational challenges. This is common for high-growth companies investing aggressively but warrants attention for mature businesses.

Asset Utilization Efficiency

Asset turnover ratio of 0.64x indicates moderate asset turnover common in capital-intensive industries such as utilities, real estate, or heavy manufacturing. Lower turnover in these sectors is expected due to the significant infrastructure required for operations.

Financial Strength & Leverage

Current ratio of 2.09 demonstrates strong short-term liquidity with current assets significantly exceeding current liabilities. This provides a substantial buffer for meeting near-term obligations and handling unexpected financial needs.

Mirum Pharmaceuticals, Inc. (MIRM) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Mirum Pharmaceuticals, Inc. stock analysis.

Deep dive into Mirum Pharmaceuticals, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Mirum Pharmaceuticals, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Mirum Pharmaceuticals, Inc.:

P/B Ratio 25.01x
Market Cap $6.06B
Book Value/Share $3.98
Revenue/Share $9.35
FCF/Share $-2.83
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Mirum Pharmaceuticals, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Mirum Pharmaceuticals, Inc.: An ROE of -32.2% indicates room for improvement in shareholder value creation.

ROE -32.2%
ROA -8.8%
ROIC -13.1%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Mirum Pharmaceuticals, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Mirum Pharmaceuticals, Inc.: A current ratio of 2.09 indicates strong liquidity.

Current Ratio 2.09x
Quick Ratio 1.99x
D/E Ratio 2.67x
Financial Leverage 3.67x
Interest Coverage 0.4x
Working Capital $297M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Mirum Pharmaceuticals, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Mirum Pharmaceuticals, Inc.: Free cash flow of $-173M indicates cash challenges that need attention.

Operating Cash Flow -$42M
Free Cash Flow -$173M
Capital Spending -$131M
FCF/Sales -30.3%
CapEx/Sales 23.0%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Mirum Pharmaceuticals, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Mirum Pharmaceuticals, Inc.: An asset turnover of 0.64x suggests room for improvement in asset utilization.

Asset Turnover 0.64x
Receivables Turnover 4.3x
Fixed Assets Turnover 236.2x
Days Sales Outstanding 85 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Mirum Pharmaceuticals, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Mirum Pharmaceuticals, Inc.: With annual revenue of $569M, Mirum Pharmaceuticals, Inc. demonstrates solid business size.

Income Statement
Total Revenue $569M
Operating Income -$80M
Net Income -$78M
R&D Expense $46M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 569%
Cash & Short-term Investments 325%
Total Liabilities 648%
Short-term Debt 213%
Accounts Receivable 133%
Inventory 26%
Dividend & Shareholder Information
Shares Outstanding 61M

Latest Mirum Pharmaceuticals, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Mirum Pharmaceuticals, Inc. (MIRM) stock price and investment outlook.

More news available

Sign up free to read all 9 news articles and stay updated on market developments.

Sign Up Free to Read More

Mirum Pharmaceuticals, Inc. Competitors & Peer Analysis - Life Sciences Sector

Comparative analysis of Mirum Pharmaceuticals, Inc. against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
Aardvark Therapeutics, Inc. AARD ██% $79M x 0.9x
Abbvie Inc. ABBV ██% $397.60B 109.4x x
Abcellera Biologics Inc. ABCL ██% $1.60B x 1.7x
Abeona Therapeutics Inc. ABEO ██% $314M 4.8x 2.2x
Abbott Laboratories ABT ██% $156.15B 24.9x 3.0x
Arbutus Biopharma Corp ABUS ██% $845M 5.3x 3.3x
Abvc Biopharma, Inc. ABVC ██% $34M x 3.1x
Abivax S.A. ABVX ██% $7.92B x x
Acadia Pharmaceuticals Inc ACAD ██% $3.66B 9.7x 2.9x
Adicet Bio, Inc. ACET ██% $71M x 0.5x
Aclaris Therapeutics, Inc. ACRS ██% $610M x 4.3x
Acrivon Therapeutics, Inc. ACRV ██% $56M x 0.6x
Actuate Therapeutics, Inc. ACTU ██% $120M x 11.0x
Accustem Sciences Inc. ACUT ██% $4M x x
Acurx Pharmaceuticals, Inc. ACXP ██% $7M x 1.0x
Adagene Inc. ADAG ██% $237M x 6.2x
Adc Therapeutics Sa ADCT ██% $135M x x
Adial Pharmaceuticals, Inc. ADIL ██% $6M x 1.7x
Aditxt, Inc. ADTX ██% $10K x x
Addex Therapeutics Ltd. ADXN ██% $8M x x
Aeon Biopharma, Inc. AEON ██% $18M x x
Agios Pharmaceuticals, Inc. AGIO ██% $1.70B x 1.5x
Akebia Therapeutics, Inc. AKBA ██% $241M x 8.8x
Akero Therapeutics, Inc. AKRO ██% $4.38B -8.7x 4.6x
Akari Therapeutics Plc AKTX ██% $23M x 1.6x
Aldeyra Therapeutics, Inc. ALDX ██% $103M x 2.5x
Alkermes Plc. ALKS ██% $7.48B 49.0x 4.3x
Allarity Therapeutics, Inc. ALLR ██% $25M x 3.5x
Alumis Inc. ALMS ██% $2.61B x 4.6x
Alnylam Pharmaceuticals, Inc. ALNY ██% $38.31B 122.1x 48.5x
Altimmune, Inc. ALT ██% $504M x 1.8x
Alx Oncology Holdings Inc ALXO ██% $205M x 1.4x
Alzamend Neuro, Inc. ALZN ██% $4M x 2.0x
Amylyx Pharmaceuticals, Inc. AMLX ██% $1.54B x 5.7x
Amphastar Pharmaceuticals, Inc. AMPH ██% $916M 11.6x 1.2x
Amarin Corp Plc\Uk AMRN ██% $312M x 0.7x
Amneal Pharmaceuticals, Inc. AMRX ██% $5.16B 42.3x x
Anaptysbio, Inc ANAB ██% $1.57B x 123.5x
Anebulo Pharmaceuticals, Inc. ANEB ██% $16M x 2.1x
Ani Pharmaceuticals Inc ANIP ██% $1.71B 18.5x 3.0x
Anixa Biosciences Inc ANIX ██% $84M x 5.8x
Annexon, Inc. ANNX ██% $716M x 3.5x
Alto Neuroscience, Inc. ANRO ██% $751M x 3.1x
An2 Therapeutics, Inc. ANTX ██% $160M x 2.0x
Annovis Bio, Inc. ANVS ██% $78M x 24.9x
Apollomics Inc. APLM ██% $30M x x
Apellis Pharmaceuticals, Inc. APLS ██% $5.25B 39.4x 12.7x
Applied Therapeutics, Inc. APLT ██% $15M -0.7x 0.9x
Aprea Therapeutics, Inc. APRE ██% $9M x 0.2x
Apimeds Pharmaceuticals Us, Inc. APUS ██% $19M x 0.2x
Aptevo Therapeutics Inc. APVO ██% $6M x 0.5x
Aquestive Therapeutics, Inc. AQST ██% $523M x x
Arcturus Therapeutics Holdings Inc. ARCT ██% $198M x 1.0x
Ardelyx, Inc. ARDX ██% $1.43B x 9.6x
Arcutis Biotherapeutics, Inc. ARQT ██% $3.07B x 16.2x
Artelo Biosciences, Inc. ARTL ██% $5M x 0.7x
Arvinas, Inc. ARVN ██% $457M x 1.2x
Arrowhead Pharmaceuticals, Inc. ARWR ██% $10.46B x 17.0x
Aspire Biopharma Holdings, Inc. ASBP ██% $8M x 2.0x
Assembly Biosciences, Inc. ASMB ██% $446M x 2.3x
Ascendis Pharma A/S ASND ██% $13.36B x x
Assertio Holdings, Inc. ASRT ██% $151M x 2.0x
Atai Beckley N.V. ATAI ██% $1.40B x 8.8x
Alterity Therapeutics Ltd ATHE ██% $74M x x
Actinium Pharmaceuticals, Inc. ATNM ██% $33M x 14.2x
Atossa Therapeutics, Inc. ATOS ██% $22M x 0.7x
Avenue Therapeutics, Inc. ATXI ██% $1M x 1.0x
Astria Therapeutics, Inc. ATXS ██% $710M -4.7x 3.0x
Aurinia Pharmaceuticals Inc. AUPH ██% $2.07B 7.0x 3.7x
Arrivent Biopharma, Inc. AVBP ██% $1.37B x 4.2x
Avadel Pharmaceuticals Plc AVDL ██% $2.10B -10.2x 21.4x
Atea Pharmaceuticals, Inc. AVIR ██% $349M x 1.5x
Avalo Therapeutics, Inc. AVTX ██% $719M x 10.5x
Axim Biotechnologies, Inc. AXIM ██% $2M x x
Axsome Therapeutics, Inc. AXSM ██% $13.05B x 239.1x
Aytu Biopharma, Inc AYTU ██% $27M -0.3x 1.2x
Azitra, Inc. AZTR ██% $4M x 0.3x
Bridgebio Pharma, Inc. BBIO ██% $13.22B x x
Bridgebio Oncology Therapeutics, Inc. BBOT ██% $597M x 1.6x
Bicara Therapeutics Inc. BCAX ██% $1.39B x 2.7x
Briacell Therapeutics Corp. BCTX ██% $24M x 1.0x
Bicycle Therapeutics Plc BCYC ██% $286M x 0.5x
Bioadaptives, Inc. BDPT ██% $50K x x
Biodexa Pharmaceuticals Plc BDRX ██% $510K x x
Beone Medicines Ltd. BEIGF ██% $36.38B 530.6x 8.8x
Bullfrog Ai Holdings, Inc. BFRG ██% $12M x 2.4x
Biofrontera Inc. BFRI ██% $11M x 1.7x
Bio Green Med Solution, Inc. BGMS ██% $5M x 0.7x
Bausch Health Companies Inc. BHC ██% $1.93B x x
Bioharvest Sciences Inc. BHST ██% $73M x 2.9x
Biohaven Ltd. BHVN ██% $1.22B -4.6x 23.4x
Bioage Labs, Inc. BIOA ██% $730M x 1.9x
Bio Essence Corp BIOE ██% $12M 9.1x x
Biovie Inc. BIVI ██% $13M x 0.8x
Bioxytran, Inc BIXT ██% $4M x x
Biolinerx Ltd. BLRX ██% $16M x x
Belite Bio, Inc BLTE ██% $5.38B x 7.0x
Biomea Fusion, Inc. BMEA ██% $86M x 4.6x
Biomarin Pharmaceutical Inc BMRN ██% $10.73B 39.9x 1.7x
Bristol Myers Squibb Co BMY ██% $115.96B 15.9x 5.8x
Bristol Myers Squibb Co BMYMP ██% $1.73T 287.0x 93.4x
Benitec Biopharma Inc. BNTC ██% $380M x 2.1x
Boundless Bio, Inc. BOLD ██% $31M x 0.4x
Bolt Biotherapeutics, Inc. BOLT ██% $9M x 0.5x
Bio-Path Holdings, Inc. BPTH ██% $2M x x
Bioquest Corp BQST ██% $2M x x
Barinthus Biotherapeutics Plc. BRNS ██% $30M x 0.5x
Bespoke Extracts, Inc. BSPK ██% $2M x x
Bioxcel Therapeutics, Inc. BTAI ██% $34M x x
Beyondspring Inc. BYSI ██% $68M x x
Calcimedica, Inc. CALC ██% $14M x x
Camp4 Therapeutics Corp CAMP ██% $208M -0.1x 4.4x
Can-Fite Biopharma Ltd. CANF ██% $6M x 1.1x
Capricor Therapeutics, Inc. CAPR ██% $1.44B x 5.2x
Carisma Therapeutics Inc. CARM ██% $0.00M 0.0x x
Casi Pharmaceuticals, Inc. CASI ██% $5M -1.4x 2.5x
Perspective Therapeutics, Inc. CATX ██% $339M x 1.0x
Gyre Therapeutics, Inc. CBIO ██% $506M x 5.0x
Cdt Equity Inc. CDT ██% $3M x 0.8x
Cingulate Inc. CING ██% $69M x 3.6x
Cell Source, Inc. CLCS ██% $52M x x
Clene Inc. CLNN ██% $65M x x
Cellectar Biosciences, Inc. CLRB ██% $18M x 5.4x
Clearside Biomedical, Inc. CLSD ██% $4M -2.0x -0.7x
Clearside Biomedical, Inc. CLSDQ ██% $2M x x
Climb Bio, Inc. CLYM ██% $625M x 4.2x
Chemomab Therapeutics Ltd. CMMB ██% $13M x 1.0x
Clearmind Medicine Inc. CMND ██% $3M x x
Compass Pathways Plc CMPS ██% $1.54B x 4.7x
Cnbx Pharmaceuticals Inc. CNBX ██% $110K x x
Cns Pharmaceuticals, Inc. CNSP ██% $7M x 97.6x
Centessa Pharmaceuticals Plc CNTA ██% $6.15B x 12.6x
Connect Biopharma Holdings Ltd CNTB ██% $132M x 3.1x
Canton Strategic Holdings, Inc. CNTN ██% $211M x 0.5x
Context Therapeutics Inc. CNTX ██% $130M x 2.5x
Cocrystal Pharma, Inc. COCP ██% $14M x 3.4x
Cogent Biosciences, Inc. COGT ██% $5.57B x 9.2x
Collegium Pharmaceutical, Inc COLL ██% $1.11B 14.9x 3.6x
Corcept Therapeutics Inc CORT ██% $8.69B 183.6x 13.6x
Coya Therapeutics, Inc. COYA ██% $109M x 2.2x
China Pharma Holdings, Inc. CPHI ██% $31M x 0.8x
Cumberland Pharmaceuticals Inc CPIX ██% $85M x 3.9x
Cannapharmarx, Inc. CPMD ██% $1M x x
Catalyst Pharmaceuticals, Inc. CPRX ██% $3.83B 17.3x 3.8x
Corbus Pharmaceuticals Holdings, Inc. CRBP ██% $138M x 1.1x
Cormedix Inc. CRMD ██% $702M 3.9x 1.6x
Crinetics Pharmaceuticals, Inc. CRNX ██% $3.53B x 2.8x
Cervomed Inc. CRVO ██% $23M x 2.1x
Corvus Pharmaceuticals, Inc. CRVS ██% $975M x 4.1x
Cytomx Therapeutics, Inc. CTMX ██% $649M x 2.0x
Contineum Therapeutics, Inc. CTNM ██% $443M x 1.8x
Citius Oncology, Inc. CTOR ██% $64M x 1.8x
Hepion Pharmaceuticals, Inc. CTRVP ██% $20K x 0.0x
Ctt Pharmaceutical Holdings, Inc. CTTH ██% $4M x 6.0x
Citius Pharmaceuticals, Inc. CTXR ██% $16M x 0.3x
Cue Biopharma, Inc. CUE ██% $114M x 5.3x
Curanex Pharmaceuticals Inc CURX ██% $10M x 1.2x
Cadrenal Therapeutics, Inc. CVKD ██% $12M x 6.9x
Cv Sciences, Inc. CVSI ██% $6M x 3.9x
Cyclerion Therapeutics, Inc. CYCN ██% $14M x 2.0x
Cytodyn Inc. CYDY ██% $394M x x
Cypherpunk Technologies Inc. CYPH ██% $72M x 0.9x
Cryoport, Inc. CYRX ██% $722M 9.1x 1.5x
Cytokinetics Inc CYTK ██% $9.40B x x
Dare Bioscience, Inc. DARE ██% $30M x 40.2x
Day One Biopharmaceuticals, Inc. DAWN ██% $2.22B x 5.0x
Decoy Therapeutics Inc. DCOY ██% $3M x 0.8x
Journey Medical Corp DERM ██% $171M x 5.6x
Diamedica Therapeutics Inc. DMAC ██% $294M x 6.2x
Damora Therapeutics, Inc. DMRA ██% $1.31B x 2.6x
Dianthus Therapeutics, Inc. /De/ DNTH ██% $4.17B x 3.5x
Dermata Therapeutics, Inc. DRMA ██% $5M x 0.8x
Bright Minds Biosciences Inc. DRUG ██% $604M x x
Design Therapeutics, Inc. DSGN ██% $658M x 3.0x
Dynavax Technologies Corp DVAX ██% $1.82B 88.2x 3.4x
Dogwood Therapeutics, Inc. DWTX ██% $52M x 0.7x
Dyne Therapeutics, Inc. DYN ██% $2.97B x 3.4x
Emergent Biosolutions Inc. EBS ██% $435M x 0.8x
Edesa Biotech, Inc. EDSA ██% $50M x 4.9x
Eagle Pharmaceuticals, Inc. EGRX ██% $4M 0.4x 0.0x
Pmgc Holdings Inc. ELAB ██% $7M x 0.6x
Elanco Animal Health Inc ELAN ██% $12.01B x 1.9x
Eledon Pharmaceuticals, Inc. ELDN ██% $271M x 6.1x
Elite Pharmaceuticals Inc /Nv/ ELTP ██% $376M 13.7x 4.7x
Elicio Therapeutics, Inc. ELTX ██% $260M x x
Enliven Therapeutics, Inc. ELVN ██% $2.46B x 5.4x
Emmaus Life Sciences, Inc. EMMA ██% $770K x x
Enlivex Ltd. ENLV ██% $173M 0.1x 0.1x
Ensysce Biosciences, Inc. ENSC ██% $4M x x
Enanta Pharmaceuticals Inc ENTA ██% $334M x 2.9x
Gridai Technologies Corp. ENTO ██% $7M 0.0x 0.3x
Enveric Biosciences, Inc. ENVB ██% $7M x 1.3x
Evolus, Inc. EOLS ██% $429M x x
Essa Pharma Inc. EPIX ██% $9M -2.7x 0.1x
Eupraxia Pharmaceuticals Inc. EPRX ██% $394M x 4.8x
Equillium, Inc. EQ ██% $178M x 3.0x
Erasca, Inc. ERAS ██% $4.35B x 11.1x
Ernexa Therapeutics Inc. ERNA ██% $8M x 1.1x
Esperion Therapeutics, Inc. ESPR ██% $792M x x
89bio, Inc. ETNB ██% $2.20B -3.5x 4.2x
Eton Pharmaceuticals, Inc. ETON ██% $879M x 28.7x
Earth Science Tech, Inc. ETST ██% $52M 12.8x 9.1x
Evofem Biosciences, Inc. EVFM ██% $930K x x
Evommune, Inc. EVMN ██% $745M x 2.5x
Edgewise Therapeutics, Inc. EWTX ██% $3.65B x 7.4x
Fuss Brands Corp. FBDS ██% $2M x 0.0x
Fortress Biotech, Inc. FBIO ██% $92M 0.7x 0.6x
Fortress Biotech, Inc. FBIOP ██% $394M 98.8x 7.1x
Fibrobiologics, Inc. FBLG ██% $5M x 1.9x
Forte Biosciences, Inc. FBRX ██% $356M x 8.5x
Fibrogen Inc FGEN ██% $35M 0.2x -3.6x
Foghorn Therapeutics Inc. FHTX ██% $238M x x
Filana Therapeutics, Inc. FLNA ██% $63M x 0.9x
Amicus Therapeutics, Inc. FOLD ██% $4.50B x 16.4x
Fulcrum Therapeutics, Inc. FULC ██% $236M x 0.7x
Galectin Therapeutics Inc GALT ██% $172M x x
Gain Therapeutics, Inc. GANX ██% $72M x 5.1x
Generation Bio Co. GBIO ██% $36M -0.6x 0.7x
Greater Cannabis Company, Inc. GCAN ██% $160K x x
Cytomed Therapeutics Ltd GDTC ██% $13M x x
Geron Corp GERN ██% $744M x 3.3x
Gh Research Plc GHRS ██% $1.28B x x
Galmed Pharmaceuticals Ltd. GLMD ██% $4M x 0.3x
Lakefront Biotherapeutics Nv GLPG ██% $1.85B x x
Greenwich Lifesciences, Inc. GLSI ██% $338M x 64.1x
Galecto, Inc. GLTO ██% $1.59B -2.5x 198.2x
Genelux Corp GNLX ██% $129M x 5.6x
Genprex, Inc. GNPX ██% $7M x 0.4x
Gossamer Bio, Inc. GOSS ██% $87M x x
Geovax Labs, Inc. GOVX ██% $6M x 12.5x
Structure Therapeutics Inc. GPCR ██% $3.08B x 2.1x
Grace Therapeutics, Inc. GRCE ██% $36M x 0.6x
Gri Bio, Inc. GRI ██% $4M x 0.4x
Galera Therapeutics, Inc. GRTX ██% $17M 0.1x 23.7x
Gsk Plc GSK ██% $106.00B x x
Gt Biopharma, Inc. GTBP ██% $16M x 2.1x
Gyre Therapeutics, Inc. GYRE ██% $554M x 5.5x
Hutchmed (China) Ltd HCM ██% $1.84B 2.0x 1.5x
Hcw Biologics Inc. HCWB ██% $9M x 1.6x
Cybin Inc. HELP ██% $202M x x
Hepion Pharmaceuticals, Inc. HEPA ██% $2M x 0.9x
Vyome Holdings, Inc HIND ██% $16M x 2.4x
Hutchmed (China) Ltd HMDCF ██% $2.64B x 2.1x
Hookipa Pharma Inc. HOOK ██% $14M x 0.4x
Rocket One Inc. HOTH ██% $42M x 10.2x
Werewolf Therapeutics, Inc. HOWL ██% $19M x 1.6x
Harmony Biosciences Holdings, Inc. HRMY ██% $2.04B 14.0x 2.2x
Heron Therapeutics, Inc. /De/ HRTX ██% $78M x 8.5x
Hst Global, Inc. HSTC ██% $99M x 79.9x
Tuhura Biosciences, Inc./Nv HURA ██% $139M x 6.0x
Mindwalk Holdings Corp. HYFT ██% $77M x x
Hyperion Defi, Inc. HYPD ██% $40M x 0.7x
Ibio, Inc. IBIO ██% $83M x 1.1x
Impact Biomedical Inc. IBO ██% $60M x 5.3x
Ideaya Biosciences, Inc. IDYA ██% $2.53B x 2.7x
Inflarx N.V. IFRX ██% $247M x x
Igc Pharma, Inc. IGC ██% $28M x 4.5x
Immutep Ltd IMMP ██% $53M x x
Immix Biopharma, Inc. IMMX ██% $577M x 6.8x
Immunome Inc. IMNM ██% $2.08B x 3.5x
Imunon, Inc. IMNN ██% $8M x 2.4x
Immuron Ltd IMRN ██% $10M x x
Immuneering Corp IMRX ██% $266M x 1.3x
Eom Pharmaceutical Holdings, Inc. IMUC ██% $6M x 1.8x
Immunic, Inc. IMUX ██% $178M x 1.2x
Integrated Biopharma Inc INBP ██% $6M x 0.3x
Indaptus Therapeutics, Inc. INDP ██% $404M x 324.0x
Indivior Pharmaceuticals, Inc. INDV ██% $4.73B 18.8x x
Inmed Pharmaceuticals Inc. INM ██% $5M x 0.8x
Inovio Pharmaceuticals, Inc. INO ██% $90M x 14.9x
Insmed Inc INSM ██% $20.94B x 29.7x
Inhibitor Therapeutics, Inc. INTI ██% $15M x x
Innoviva, Inc. INVA ██% $1.66B 3.3x 1.2x
Io Biotech, Inc. IOBT ██% $540K x 0.6x
Io Biotech, Inc. IOBTQ ██% $490K x 0.5x
Ionis Pharmaceuticals Inc IONS ██% $12.25B x 24.9x
Opus Genetics, Inc. IRD ██% $323M x x
Disc Medicine, Inc. IRON ██% $2.60B x 3.8x
Ironwood Pharmaceuticals Inc IRWD ██% $598M 5.9x x
International Stem Cell Corp ISCO ██% $1M x x
Iterum Therapeutics Plc ITRM ██% $1M x x
Inventiva S.A. IVA ██% $794M x x
Incannex Healthcare Inc. IXHL ██% $46M x 0.6x
Jaguar Health, Inc. JAGX ██% $2M x x
Janux Therapeutics, Inc. JANX ██% $831M x 0.9x
Jazz Pharmaceuticals Plc JAZZ ██% $14.62B 495.7x 3.2x
Jade Biosciences, Inc. JBIO ██% $979M x 3.3x
Johnson & Johnson JNJ ██% $574.07B 27.3x 7.1x
Jupiter Neurosciences, Inc. JUNS ██% $10M x x
Kala Bio, Inc. KALA ██% $46M x 4.3x
Kalvista Pharmaceuticals, Inc. KALV ██% $1.38B x x
Kairos Pharma, Ltd. KAPA ██% $10M x 1.9x
Kaya Holdings, Inc. KAYS ██% $14M x x
Kamada Ltd KMDA ██% $429M x x
Kiniksa Pharmaceuticals International, Plc KNSA ██% $3.95B 54.0x 6.5x
Kiora Pharmaceuticals Inc KPRX ██% $7M -2.4x 0.3x
Karyopharm Therapeutics Inc. KPTI ██% $203M x x
Keros Therapeutics, Inc. KROS ██% $198M x 0.7x
Korro Bio, Inc. KRRO ██% $152M x 1.3x
Pasithea Therapeutics Corp. KTTA ██% $20M x 0.4x
Kura Oncology, Inc. KURA ██% $786M x 7.3x
Kyntra Bio, Inc. KYNB ██% $27M 0.2x x
Kezar Life Sciences, Inc. KZR ██% $54M x 0.8x
Lb Pharmaceuticals Inc LBRX ██% $818M x 2.2x
Legend Biotech Corp LEGN ██% $6.74B x x
Lexaria Bioscience Corp. LEXX ██% $16M x 2.4x
Lifecore Biomedical, Inc. \De\ LFCR ██% $212M x x
Lifevantage Corp LFVN ██% $120M 15.1x 3.6x
Ligand Pharmaceuticals Inc LGND ██% $5.10B 33.2x 5.1x
Longeveron Inc. LGVN ██% $24M x 1.5x
Lianbio LIANY ██% $12M x 0.1x
Lftd Partners Inc. LIFD ██% $2M x 0.3x
Lipella Pharmaceuticals Inc. LIPO ██% $370K x 0.3x
Lite Strategy, Inc. LITS ██% $26M x 0.5x
Lixte Biotechnology Holdings, Inc. LIXT ██% $126M x 15.9x
Lixte Biotechnology Holdings, Inc. LIXTW ██% $130K x 0.0x
Lakefront Biotherapeutics Nv LKFT ██% $1.91B x x
Eli Lilly & Co LLY ██% $1.04T 41.1x 33.3x
Lunai Bioworks Inc. LNAI ██% $11M x x
Lipocine Inc. LPCN ██% $16M x 0.7x
Cypherpunk Technologies Inc. LPTX ██% $94M -1.1x 35.1x
Liquidia Corp LQDA ██% $6.33B 283.6x 58.3x
Larimar Therapeutics, Inc. LRMR ██% $374M x 2.4x
Lisata Therapeutics, Inc. LSTA ██% $32M x 2.9x
Lantern Pharma Inc. LTRN ██% $52M x 15.1x
Lava Therapeutics Nv LVTX ██% $46M x 3.6x
Lexicon Pharmaceuticals, Inc. LXRX ██% $805M x 4.0x
Lyell Immunopharma, Inc. LYEL ██% $320M x 1.2x
Maia Biotechnology, Inc. MAIA ██% $79M x 2.9x
Mustang Bio, Inc. MBIO ██% $6M x 0.7x
Moleculin Biotech, Inc. MBRX ██% $14M x 1.0x
Mbx Biosciences, Inc. MBX ██% $1.77B x 4.1x
Seres Therapeutics, Inc. MCRB ██% $61M x 2.3x
Medicus Pharma Ltd. MDCX ██% $19M x 14.2x
Medicus Pharma Ltd. MDCXW ██% $52M x x
Madrigal Pharmaceuticals, Inc. MDGL ██% $10.93B x 20.1x
Chrome Holding Co. MEHCQ ██% $96M x x
Macrogenics Inc MGNX ██% $255M x 12.0x
Mira Pharmaceuticals, Inc. MIRA ██% $40M x 4.3x
Mirum Pharmaceuticals, Inc. MIRM ██% $6.06B x 25.0x
Milestone Pharmaceuticals Inc. MIST ██% $150M x 4.2x
Moonlake Immunotherapeutics MLTX ██% $1.27B x 5.0x
Mineralys Therapeutics, Inc. MLYS ██% $1.97B x 3.1x
Mannkind Corp MNKD ██% $1.16B x x
Medicinova Inc MNOV ██% $63M x 1.6x
Monopar Therapeutics MNPR ██% $396M x 2.9x
Maplight Therapeutics, Inc. MPLT ██% $1.37B x 3.4x
Mereo Biopharma Group Plc MREO ██% $50M x 1.5x
Merck & Co., Inc. MRK ██% $298.52B 33.4x 6.5x
Marker Therapeutics, Inc. MRKR ██% $23M x 1.7x
Mersana Therapeutics, Inc. MRSN ██% $145M -3.4x -1.4x
Merus N.V. MRUS ██% $6.83B -13.5x 8.8x
Maravai Lifesciences Holdings, Inc. MRVI ██% $1.92B x 9.1x
Matinas Biopharma Holdings, Inc. MTNB ██% $5M x 1.7x
Metsera, Inc. MTSR ██% $7.41B x 22.0x
Metavia Inc. MTVA ██% $10M x 1.1x
Mural Oncology Plc MURA ██% $35M x 0.6x
Mainz Biomed N.V. MYNZ ██% $7M x x
Newamsterdam Pharma Co N.V. NAMS ██% $3.53B x 5.3x
Newamsterdam Pharma Co N.V. NAMSW ██% $2.59B x 3.6x
Natures Sunshine Products Inc NATR ██% $358M 18.0x 2.2x
Novabridge Biosciences NBP ██% $170M x 0.7x
Nanobiotix S.A. NBTX ██% $1.49B x x
Stablecoin Development Corp NBY ██% $37M x x
Newcelx Ltd. NCEL ██% $18M x 32.4x
Nucana Plc NCNA ██% $8M x x
Minerva Neurosciences, Inc. NERV ██% $203M x x
Neuphoria Therapeutics Inc. NEUP ██% $24M x 0.8x
Neurogene Inc. NGNE ██% $453M x 1.9x
Nika Pharmaceuticals, Inc NIKA ██% $212M x x
Nektar Therapeutics NKTR ██% $2.00B x 3.5x
Nkarta, Inc. NKTX ██% $205M x 0.7x
Newcelx Ltd. NLSP ██% $54M x 98.9x
Newcelx Ltd. NLSPW ██% $120K x 0.2x
Nanoviricides, Inc. NNVC ██% $30M x 3.2x
Nurix Therapeutics, Inc. NRIX ██% $1.76B x 3.7x
Neurosense Therapeutics Ltd. NRSN ██% $27M x x
Nrx Pharmaceuticals, Inc. NRXP ██% $168M x x
Neonc Technologies Holdings, Inc. NTHI ██% $112M x x
Nuvation Bio Inc. NUVB ██% $1.65B x 5.2x
Nuvalent, Inc. NUVL ██% $9.71B x 8.3x
Nuvectis Pharma, Inc. NVCT ██% $279M x 19.6x
Novartis Ag NVS ██% $293.70B x x
Northwest Biotherapeutics Inc NWBO ██% $305M x x
Nexien Biopharma, Inc. NXEN ██% $10K x x
Nextcure, Inc. NXTC ██% $8M x 0.3x
Nexentis Technologies Inc. NXTS ██% $4M x 0.3x
Ocean Biomedical, Inc. OCEA ██% $190K -0.3x 0.1x
Ocular Therapeutix, Inc OCUL ██% $1.90B x 3.3x
Oragenics Inc OGEN ██% $3M x 0.4x
Organigram Global Inc. OGI ██% $152M x x
Organon & Co. OGN ██% $3.52B 14.3x 3.9x
Onkure Therapeutics, Inc. OKUR ██% $172M x 0.9x
Olema Pharmaceuticals, Inc. OLMA ██% $852M x 1.8x
Omeros Corp OMER ██% $733M 8.5x x
Beone Medicines Ltd. ONC ██% $27.00B 52.6x 5.7x
Onconetix, Inc. ONCO ██% $4M x 0.3x
Oncolytics Biotech Inc ONCY ██% $95M x x
Opko Health, Inc. OPK ██% $1.10B x 0.9x
Organogenesis Holdings Inc. ORGO ██% $306M 112.6x 1.3x
Orgenesis Inc. ORGS ██% $3M x x
Oric Pharmaceuticals, Inc. ORIC ██% $809M x 2.0x
Oruka Therapeutics, Inc. ORKA ██% $4.13B x 8.5x
Oramed Pharmaceuticals Inc. ORMP ██% $156M 1.4x 0.7x
Os Therapies Inc OSTX ██% $75M x x
Oncotelic Therapeutics, Inc. OTLC ██% $22M x 0.1x
Ovid Therapeutics Inc. OVID ██% $412M x 2.1x
One World Products, Inc. OWPC ██% $660K x x
Phibro Animal Health Corp PAHC ██% $1.26B 13.3x 3.5x
Prestige Consumer Healthcare Inc. PBH ██% $2.38B 12.5x 1.3x
Psyence Biomedical Ltd. PBM ██% $8M x x
Puma Biotechnology, Inc. PBYI ██% $357M 14.7x 2.8x
Pacira Biosciences, Inc. PCRX ██% $921M 179.2x 1.4x
Processa Pharmaceuticals, Inc. PCSA ██% $5M x 2.1x
Procyon Corp PCYN ██% $2M x 0.7x
Pds Biotechnology Corp PDSB ██% $63M x 16.1x
Pepgen Inc. PEPG ██% $95M x 0.7x
Pfizer Inc PFE ██% $148.93B 19.9x 1.7x
Precigen, Inc. PGEN ██% $1.61B x 79.7x
Phathom Pharmaceuticals, Inc. PHAT ██% $816M x x
Phio Pharmaceuticals Corp. PHIO ██% $12M x 0.8x
Pharvaris N.V. PHVS ██% $2.20B x x
Protokinetix, Inc. PKTX ██% $2M x 8.1x
Plandai Biotechnology, Inc. PLPL ██% $4M x 14.6x
Pliant Therapeutics, Inc. PLRX ██% $72M x 0.4x
Polomar Health Services, Inc. PMHS ██% $2M x x
Promis Neurosciences Inc. PMN ██% $91M x 1.5x
Pmv Pharmaceuticals, Inc. PMVP ██% $57M x 0.6x
Purple Biotech Ltd. PPBT ██% $3M x x
Propanc Biopharma, Inc. PPCB ██% $3M x 0.3x
Praxis Precision Medicines, Inc. PRAX ██% $6.70B x 4.8x
Prf Technologies Ltd. PRFX ██% $1M x 0.2x
Perrigo Co Plc PRGO ██% $1.54B x 0.6x
Prelude Therapeutics Inc PRLD ██% $326M x 5.4x
Prophase Labs, Inc. PRPH ██% $1M x 0.2x
Proqr Therapeutics N.V. PRQR ██% $149M x x
Prothena Corp Public Ltd Co PRTA ██% $420M x 1.3x
Ptc Therapeutics, Inc. PTCT ██% $6.08B x x
Protagonist Therapeutics, Inc PTGX ██% $6.79B x 10.4x
Protagenic Therapeutics, Inc.\New PTIX ██% $1M x x
Palatin Technologies Inc PTN ██% $24M x 2.3x
Palatin Technologies Inc PTNT ██% $17M x 43.1x
Petros Pharmaceuticals, Inc. PTPI ██% $300K 0.1x 0.2x
Pulmatrix, Inc. PULM ██% $5M x 1.4x
Provectus Biopharmaceuticals, Inc. PVCT ██% $29M x x
Palvella Therapeutics, Inc. PVLA ██% $1.46B x 6.3x
Pyxis Oncology, Inc. PYXS ██% $105M x 3.4x
Aixcrypto Holdings, Inc. QLGN ██% $8M -1.3x 0.2x
Quoin Pharmaceuticals, Ltd. QNRX ██% $10M x 1.2x
Quantum Biopharma Ltd. QNTM ██% $25M x x
Q32 Bio Inc. QTTB ██% $218M 6.6x 4.7x
Quantum Cyber N.V. QUCY ██% $44M x 9.5x
Uniqure N.V. QURE ██% $1.69B x 11.3x
Radiopharm Theranostics Ltd RADX ██% $34M x x
Rani Therapeutics Holdings, Inc. RANI ██% $108M x 3.8x
Rapport Therapeutics, Inc. RAPP ██% $1.68B x 3.6x
Rapt Therapeutics, Inc. RAPT ██% $1.56B -0.4x 10.3x
Ultragenyx Pharmaceutical Inc. RARE ██% $2.26B x x
Rocket Pharmaceuticals, Inc. RCKT ██% $284M x 1.2x
Arcus Biosciences, Inc. RCUS ██% $2.78B x 5.3x
Dr Reddys Laboratories Ltd RDY ██% $11.10B x x
Regeneron Pharmaceuticals, Inc. REGN ██% $62.57B 14.2x 2.0x
Revelation Biosciences, Inc. REVB ██% $4M x 0.3x
Rafael Holdings, Inc. RFL ██% $91M x 1.2x
Regen Biopharma Inc RGBP ██% $100K x x
Regen Biopharma Inc RGBPP ██% $470K x x
Rigel Pharmaceuticals Inc RIGL ██% $569M 1.6x 1.4x
Rocket One Inc. RKTO ██% $30M x 7.1x
Relmada Therapeutics, Inc. RLMD ██% $669M x 3.1x
Rallybio Corp RLYB ██% $84M x 1.7x
Retrieve Medical Holdings, Inc. RMHI ██% $24M x x
Rockwell Medical, Inc. RMTI ██% $26M x 0.7x
Avidity Biosciences, Inc. RNA ██% $206M -12.2x 0.1x
Cartesian Therapeutics, Inc. RNAC ██% $232M x x
Transcode Therapeutics, Inc. RNAZ ██% $5M x 4.0x
Rein Therapeutics, Inc. RNTX ██% $79M x 6.8x
Renovorx, Inc. RNXT ██% $38M x 3.4x
Roivant Sciences Ltd. ROIV ██% $20.47B x 4.5x
Royalty Pharma Plc RPRX ██% $31.39B 38.0x 4.6x
Repare Therapeutics Inc. RPTX ██% $114M -2.1x 1.0x
Rest Ez Inc. RTEZ ██% $1.93B x x
Rapid Therapeutic Science Laboratories, Inc. RTSL ██% $110K 1.9x 0.3x
Reviva Pharmaceuticals Holdings, Inc. RVPH ██% $10M x 0.6x
Rhythm Pharmaceuticals, Inc. RYTM ██% $5.87B x 47.7x
Rezolute, Inc. RZLT ██% $367M x 3.1x
Filana Therapeutics, Inc. SAVA ██% $101M -1.9x 1.2x
Sunshine Biopharma Inc. SBFM ██% $3M x 0.2x
Scienture Holdings, Inc. SCNX ██% $14M x 0.2x
Scpharmaceuticals Inc. SCPH ██% $302M -2.0x -50.9x
Scorpius Holdings, Inc. SCPX ██% $610K x x
Scynexis Inc SCYX ██% $330M x 8.0x
Stablecoin Development Corp SDEV ██% $29M 0.1x 0.2x
Schrodinger, Inc. SDGR ██% $1.05B x 3.3x
Septerna, Inc. SEPN ██% $1.37B x 3.6x
Serina Therapeutics, Inc. SER ██% $26M x 1.5x
Sagimet Biosciences Inc. SGMT ██% $401M x 3.9x
Shuttle Pharmaceuticals Holdings, Inc. SHPH ██% $3M x 0.9x
Siga Technologies Inc SIGA ██% $313M 15.5x 2.1x
Silo Pharma, Inc. SILO ██% $7M x 1.2x
Sionna Therapeutics, Inc. SION ██% $1.64B x 5.7x
Skinvisible, Inc. SKVI ██% $1M x x
Skye Bioscience, Inc. SKYE ██% $27M x 3.0x
Sol-Gel Technologies Ltd. SLGL ██% $239M x 10.5x
Silence Therapeutics Plc SLN ██% $283M x 5.7x
Silence Therapeutics Plc SLNCF ██% $213M x 2.9x
Soleno Therapeutics Inc SLNO ██% $2.74B 28.6x 5.5x
Salarius Pharmaceuticals, Inc. SLRX ██% $2M -0.5x 0.4x
Sellas Life Sciences Group, Inc. SLS ██% $1.30B x 12.1x
Summit Therapeutics Inc. SMMT ██% $10.13B x 18.6x
Semnur Pharmaceuticals, Inc. SMNR ██% $1.13B x x
Syndax Pharmaceuticals Inc SNDX ██% $1.56B x 37.4x
Soligenix, Inc. SNGX ██% $7M x 2.2x
Sibannac, Inc. SNNC ██% $2M x x
Sensei Biotherapeutics, Inc. SNSE ██% $15M x x
Sanofi SNY ██% $104.30B x x
Sonnet Biotherapeutics Holdings, Inc. SONN ██% $4M -1.6x 29.5x
Spruce Biosciences, Inc. SPRB ██% $130M x 3.7x
Scisparc Ltd. SPRC ██% $5M x x
Spero Therapeutics, Inc. SPRO ██% $147M 9.7x 2.8x
Ars Pharmaceuticals, Inc. SPRY ██% $920M x 15.0x
Sarepta Therapeutics, Inc. SRPT ██% $1.56B 24.0x 1.0x
Stoke Therapeutics, Inc. STOK ██% $1.77B x 4.5x
Shattuck Labs, Inc. STTK ██% $312M x 3.3x
Supernus Pharmaceuticals, Inc. SUPN ██% $2.63B x 2.4x
Savara Inc SVRA ██% $1.04B x 5.9x
60 Degrees Pharmaceuticals, Inc. SXTP ██% $4M x 0.8x
Synlogic, Inc. SYBX ██% $7M x 0.6x
Spyre Therapeutics, Inc. SYRE ██% $5.98B x 8.9x
Syros Pharmaceuticals, Inc. SYRS ██% $20K -0.1x -0.4x
Takeda Pharmaceutical Co Ltd TAK ██% $49.81B x x
Theravance Biopharma, Inc. TBPH ██% $845M 7.4x 2.9x
Alaunos Therapeutics, Inc. TCRT ██% $5M x 3.8x
Telomir Pharmaceuticals, Inc. TELO ██% $85M x 17.2x
Tenax Therapeutics, Inc. TENX ██% $281M x 2.5x
Terns Pharmaceuticals, Inc. TERN ██% $6.12B x 6.1x
Teva Pharmaceutical Industries Ltd TEVA ██% $39.72B 25.4x 4.8x
Teva Pharmaceutical Industries Ltd TEVJF ██% $38.09B 53.4x 5.3x
Tg Therapeutics, Inc. TGTX ██% $7.26B 15.7x 12.5x
Canton Strategic Holdings, Inc. THAR ██% $186M x 30.2x
Talphera, Inc. TLPH ██% $42M x 2.3x
Telix Pharmaceuticals Ltd TLX ██% $3.20B x x
Tango Therapeutics, Inc. TNGX ██% $4.13B x 10.6x
Tonix Pharmaceuticals Holding Corp. TNXP ██% $166M x 0.7x
Theriva Biologics, Inc. TOVX ██% $18M x 1.2x
Tempest Therapeutics, Inc. TPST ██% $18M x 22.3x
Traws Pharma, Inc. TRAW ██% $17M -0.6x 1.5x
Entrada Therapeutics, Inc. TRDA ██% $234M x 0.9x
Trevi Therapeutics, Inc. TRVI ██% $1.75B x 10.2x
Trevena Inc TRVN ██% $260K -1.3x 1.5x
Turn Therapeutics Inc. TTRX ██% $160M x 26.2x
Tvardi Therapeutics, Inc. TVRD ██% $25M x 1.8x
Travere Therapeutics, Inc. TVTX ██% $4.43B x 44.9x
Therapeuticsmd, Inc. TXMD ██% $22M 122.1x 0.8x
Tyra Biosciences, Inc. TYRA ██% $1.55B x 4.0x
Unicycive Therapeutics, Inc. UNCY ██% $202M x 5.4x
Upstream Bio, Inc. UPB ██% $338M x 1.1x
Urogen Pharma Ltd. URGN ██% $1.38B x x
United Therapeutics Corp UTHR ██% $23.16B 18.0x 3.9x
Vaccinex, Inc. VCNX ██% $3M x x
Vera Therapeutics, Inc. VERA ██% $2.31B x 4.6x
Veru Inc. VERU ██% $39M -0.8x 2.1x
Sb Technology Holdings, Inc. VGLS ██% $420K x x
Sb Technology Holdings, Inc. VGLSD ██% $520K x x
Vicapsys Life Sciences, Inc. VICP ██% $47M x x
Vincerx Pharma, Inc. VINC ██% $70K -0.2x 0.0x
Viracta Therapeutics, Inc. VIRX ██% $390K -0.2x 0.2x
Viking Therapeutics, Inc. VKTX ██% $3.17B x 6.3x
Vanda Pharmaceuticals Inc. VNDA ██% $365M x 1.3x
Verrica Pharmaceuticals Inc. VRCA ██% $102M x 6.3x
Viridian Therapeutics, Inc.\De VRDN ██% $1.63B x 2.6x
Vireo Growth Inc. VREOF ██% $348M x 1.4x
Verona Pharma Plc VRNA ██% $73.55B -185.1x 264.3x
Virpax Pharmaceuticals, Inc. VRPX ██% $160K 0.0x -19.5x
Vertex Pharmaceuticals Inc / Ma VRTX ██% $111.67B 25.7x 5.8x
Verastem, Inc. VSTM ██% $349M x 4.3x
Vistagen Therapeutics, Inc. VTGN ██% $23M x 0.5x
Viatris Inc VTRS ██% $18.46B x 1.3x
Vtv Therapeutics Inc. VTVT ██% $0.00M -3.3x -7.5x
Ventyx Biosciences, Inc. VTYX ██% $999M -1.0x 5.2x
Vyne Therapeutics Inc. VYNE ██% $22M x 0.9x
Whitehawk Therapeutics, Inc. WHWK ██% $192M x 1.7x
Wave Life Sciences Ltd. WVE ██% $1.12B x 2.2x
Xenetic Biosciences, Inc. XBIO ██% $7M x 1.0x
Xbiotech Inc. XBIT ██% $71M x 0.5x
Exicure, Inc. XCUR ██% $19M x 8.8x
Xenon Pharmaceuticals Inc. XENE ██% $5.02B x 3.8x
Xeris Biopharma Holdings, Inc. XERS ██% $1.20B 100.0x 92.2x
Xilio Therapeutics, Inc. XLO ██% $52M x 0.7x
Xencor Inc XNCR ██% $892M x 1.7x
Xoma Royalty Corp XOMA ██% $498M 14.7x 5.4x
Xoma Royalty Corp XOMAO ██% $312M 14.4x 3.6x
Xoma Royalty Corp XOMAP ██% $326M 15.1x 3.7x
Xtl Biopharmaceuticals Ltd XTLB ██% $6M x x
Zenas Biopharma, Inc. ZBIO ██% $1.11B x 3.3x
Zai Lab Ltd ZLAB ██% $1.93B x 2.9x
Zentalis Pharmaceuticals, Inc. ZNTL ██% $252M x 1.4x
Zomedica Corp. ZOMDF ██% $132M x 1.1x
Zoetis Inc. ZTS ██% $33.73B 12.8x 10.4x
Zevra Therapeutics, Inc. ZVRA ██% $763M 6.2x 3.7x
Zyversa Therapeutics, Inc. ZVSA ██% $1M x x
Zymeworks Inc. ZYME ██% $1.75B -8.3x 6.5x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Mirum Pharmaceuticals, Inc. Stock Forecast

How accurate are Mirum Pharmaceuticals, Inc. stock predictions?

Our AI model shows a 8% Spearman correlation coefficient for MIRM predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Mirum Pharmaceuticals, Inc. stock price forecasts?

Our analysis considers Mirum Pharmaceuticals, Inc.'s financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Mirum Pharmaceuticals, Inc. a good investment in 2025?

Based on our AI analysis, Mirum Pharmaceuticals, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Mirum Pharmaceuticals, Inc. forecasts updated?

Mirum Pharmaceuticals, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want a simpler view of Mirum Pharmaceuticals, Inc.?

View simplified analysis on AI Stock Finder →

My Portfolio

Investment Dashboard

Loading your portfolio...